Key result
In patients with cardiac implantable electronic devices, atrial high-rate episodes lasting ≥3 minutes were independently associated with an increased risk of major adverse cardio/cerebrovascular events.
Why the study?
Patients with sustained atrial high-rate episodes have a high risk of MACCE, but the prediction model and factors for the occurrence of AHRE are unknown.
Do the HATCH score and left atrial diameter predict atrial high-rate episodes (AHRE) and subsequent major adverse cardio/cerebrovascular events (MACCE) in patients with cardiac implantable electronic devices?
Cohort (n=314)
No
Do the HATCH score and left atrial diameter predict atrial high-rate episodes (AHRE) and subsequent major adverse cardio/cerebrovascular events (MACCE) in patients with cardiac implantable electronic devices?
Answers are grounded in this paper and cite their sources.
In patients with CIEDs, an AHRE duration of ≥3 minutes is independently associated with increased MACCE risk, and can be predicted by a HATCH score ≥3 and left atrial diameter ≥4 cm.
Background: Patients with sustained atrial high-rate episodes (AHRE) have a high risk of major adverse cardio/cerebrovascular events (MACCE). However, the prediction model and factors for the occurrence of AHRE are unknown. We aimed to identify independent factors and various risk models for predicting MACCE and AHRE. Methods: We retrospectively enrolled 314 consecutive patients who had cardiac implantable electronic devices (CIEDs). The primary endpoint was MACCE after AHRE ≥3, 6 min, and 6 h. Atrial high-rate episodes was defined as >175 bpm (Medtronic ® ) lasting ≥30 s. Multivariate Cox and logistic regression analysis with time-dependent covariates were used to determine variables associated with independent risk of MACCE and occurrence of AHRE ≥3 min, respectively. Results: One hundred twenty-five patients (39.8%) developed AHRE ≥3 min, 103 (32.8%) ≥6 min, and 55 (17.5%) ≥6 h. During follow-up (median 32 months), 77 MACCE occurred (incidence 9.20/100 patient years, 95% CI 5.66–18.39). The optimal AHRE cutoff value was 3 min for MACCE, with highest Youden index 1.350 (AUC, 0.716; 95% CI, 0.638–0.793; p < 0.001). Atrial high-rate episodes ≥3 min−6 h were independently associated with MACCE. HATCH score and left atrial diameter were independently associated with AHRE ≥3 min. The optimal cutoff for HATCH score was 3 and for left atrial diameter was 4 cm for AHRE ≥3 min. Conclusion: Patients with CIEDs who develop AHRE ≥3 min have an independently increased risk of MACCE. Comprehensive assessment using HATCH score and echocardiography of patients with CIEDs is warranted.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) conducted a cohort in Patients with cardiac implantable electronic devices (CIEDs) without previous atrial fibrillation (n=314). Atrial high-rate episodes (AHRE) ≥ 3 minutes vs. No AHRE ≥ 3 minutes was evaluated on Major adverse cardio/cerebrovascular events (MACCE) (HR 2.23, 95% CI 1.37-3.64, p=0.001). In patients with cardiac implantable electronic devices, atrial high-rate episodes lasting ≥3 minutes were independently associated with an increased risk of major adverse cardio/cerebrovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: